Compare LBRT & AMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | LBRT | AMRX |
|---|---|---|
| Founded | 2011 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oilfield Services/Equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.4B | 4.0B |
| IPO Year | 2017 | 2018 |
| Metric | LBRT | AMRX |
|---|---|---|
| Price | $28.22 | $13.36 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 12 | 4 |
| Target Price | ★ $23.00 | $14.75 |
| AVG Volume (30 Days) | ★ 4.6M | 1.7M |
| Earning Date | 04-30-2026 | 01-01-0001 |
| Dividend Yield | ★ 1.29% | N/A |
| EPS Growth | N/A | ★ 157.89 |
| EPS | ★ 0.89 | 0.22 |
| Revenue | ★ $4,006,116,000.00 | N/A |
| Revenue This Year | $0.02 | $6.40 |
| Revenue Next Year | $8.06 | $6.54 |
| P/E Ratio | ★ $31.26 | $60.59 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $9.50 | $6.69 |
| 52 Week High | $28.95 | $15.42 |
| Indicator | LBRT | AMRX |
|---|---|---|
| Relative Strength Index (RSI) | 66.70 | 37.65 |
| Support Level | $10.82 | $12.50 |
| Resistance Level | N/A | $13.49 |
| Average True Range (ATR) | 1.26 | 0.43 |
| MACD | -0.05 | -0.22 |
| Stochastic Oscillator | 85.87 | 13.03 |
Liberty Energy Inc is a integrated energy services and technology company focused on providing hydraulic fracturing services and related technologies to onshore oil and natural gas exploration and production (E&P) companies. The Company offers customers with hydraulic fracturing services, together with complementary services including wireline services, proppant delivery solutions, field gas processing and treating, compressed natural gas (CNG) delivery, data analytics, related goods (including sand mine operations), and technologies to facilitate lower emission completions, thereby helping customers reduce emissions profile. The company provides services across USA and Canada.
Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE - It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.